Cargando…
Glucose-lowering therapy in type 2 diabetes: New hope after the EMPA-REG outcome trial
Prevention of cardiovascular morbidity and mortality remains the key factor in the treatment of type 2 diabetes (T2DM). In the early phase of T2DM, multifactorial intervention is mandatory and glucose levels should be near normal, in particular in younger patients presenting with the highest cardiov...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Medizin
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839058/ https://www.ncbi.nlm.nih.gov/pubmed/27071968 http://dx.doi.org/10.1007/s00059-016-4427-3 |